Protalix BioTherapeutics GAAP EPS of $0.05 beats by $0.06, revenue of $19.8M beats by $6.87M — See source for full details.
$PLX
Price history, market instrument context, member research, and related headlines in one place.
PLX key statistics
NYSE AmericanUSD
52-week range
$1.6064%$3.19
Latest session $2.61–$2.78Protalix BioTherapeutics, Inc. (PLX) is a stock instrument quoted on NYSE American in USD. The most recently published price is $2.61, down $0.14 (5.09%) from the previous close of $2.75. It has traded between $2.61 and $2.78 in the latest session. Over the past year it has ranged from $1.60 to $3.19, leaving it in the upper half of its 52-week range (64%). Reported volume for the session was 1.5M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $PLX research…